Good morning :)
Place Order
Add to Watchlist

Genesis IBRC India Ltd

GENESIS Share Price

24.554.96% (+1.16)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹30 cr, stock is ranked 3,980

Stock is 2.88x as volatile as Nifty

GENESIS Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

The stock is in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹30 cr, stock is ranked 3,980

Stock is 2.88x as volatile as Nifty

GENESIS Performance & Key Metrics

GENESIS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
8.696.05
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
37.086.540.76%

GENESIS Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

GENESIS Company Profile

Genesis IBRC India Ltd develops microbial and antimicrobial products for aquaculture, agriculture, and animal husbandry.

GENESIS Similar Stocks (Peers)

Compare with peers Compare with peers 

GENESIS Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
52.29
52.29
1Y Return
16.19%
16.19%
Buy Reco %
73.33
73.33
PE Ratio
-1,276.08
-1,276.08
1Y Return
16.69%
16.69%
Buy Reco %
100.00
100.00
PE Ratio
100.91
100.91
1Y Return
6.61%
6.61%
Buy Reco %
66.67
66.67
PE Ratio
62.34
62.34
1Y Return
82.57%
82.57%
Buy Reco %
100.00
100.00
PE Ratio
-320.19
-320.19
1Y Return
216.45%
216.45%
Buy Reco %
0.00
0.00
Compare with Peers

GENESIS Forecast

GENESIS Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

GENESIS

GENESIS

Income

Balance Sheet

Cash Flow

GENESIS Income Statement

GENESIS Income Statement

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue0.070.290.050.000.000.000.000.003.673.67
Raw Materialssubtract0.000.250.000.000.000.000.000.000.160.17
Power & Fuel Costsubtract0.000.000.000.000.000.000.000.00
Employee Costsubtract0.000.050.020.010.040.040.010.04
Selling & Administrative Expensessubtract0.070.110.090.090.070.070.080.09
Operating & Other expensessubtract0.000.070.000.000.010.010.053.67
Depreciation/Amortizationsubtract0.000.000.000.000.000.000.000.000.00
Interest & Other Itemssubtract0.000.000.000.000.000.000.000.000.00
Taxes & Other Itemssubtract0.000.000.000.000.000.000.000.000.00
EPS0.00-0.17-0.05-0.08-0.09-0.09-0.11-2.922.702.69
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.00

GENESIS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

GENESIS Stock Peers

GENESIS Past Performance & Peer Comparison

GENESIS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareBiotechnology

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Genesis IBRC India Ltd8.666.05
Biocon Ltd52.292.100.28%
Onesource Specialty Pharma Ltd-1,276.0857.92
Sai Life Sciences Ltd100.9117.61

GENESIS Stock Price Comparison

Compare GENESIS with any stock or ETF
Compare GENESIS with any stock or ETF
GENESIS
Loading...

GENESIS Holdings

GENESIS Shareholdings

GENESIS Promoter Holdings Trend

GENESIS Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

GENESIS Institutional Holdings Trend

GENESIS Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

GENESIS Shareholding Pattern

GENESIS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding11.33%0.00%0.00%0.00%88.67%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

GENESIS Shareholding History

GENESIS Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

GENESIS Insider Trades & Bulk Stock Deals

GENESIS Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing GENESIS stock

smallcases containing GENESIS stock

Looks like this stock is not in any smallcase yet.

GENESIS Events

GENESIS Events

GENESIS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GENESIS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

GENESIS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GENESIS has not given any dividends in last 5 years

GENESIS Dividends

GENESIS Dividends

Hmm, looks like data is unavailable here. Please come back after some time

GENESIS Stock News & Opinions

GENESIS Stock News & Opinions

Earnings
Genesis IBRC India reports standalone net loss of Rs 0.02 crore in the March 2025 quarter

Net Loss of Genesis IBRC India reported to Rs 0.02 crore in the quarter ended March 2025 as against net loss of Rs 3.69 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net profit reported to Rs 3.50 crore in the year ended March 2025 as against net loss of Rs 3.80 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Genesis IBRC India to convene board meeting

Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.03 crore in the December 2024 quarter

Net Loss of Genesis IBRC India reported to Rs 0.03 crore in the quarter ended December 2024 as against net loss of Rs 0.02 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Genesis IBRC India to table results

Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Genesis IBRC India reports standalone net profit of Rs 3.65 crore in the September 2024 quarter

Net profit of Genesis IBRC India reported to Rs 3.65 crore in the quarter ended September 2024 as against net loss of Rs 0.02 crore during the previous quarter ended September 2023. Sales reported to Rs 3.67 crore in the quarter ended September 2024. There were no Sales reported during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.670 0 OPM %99.460 - PBDT3.65-0.02 LP PBT3.65-0.02 LP NP3.65-0.02 LP Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Genesis IBRC India schedules board meeting

Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.10 crore in the June 2024 quarter

Net Loss of Genesis IBRC India reported to Rs 0.10 crore in the quarter ended June 2024 as against net loss of Rs 0.06 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live

11 months agoCapital Market - Live
Corporate
Genesis IBRC India announces board meeting date

Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Genesis IBRC India Ltd (GENESIS) today?

    The share price of GENESIS as on 18th July 2025 is ₹24.55. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Genesis IBRC India Ltd (GENESIS) share?

    The past returns of Genesis IBRC India Ltd (GENESIS) share are
    • Past 1 week: N/A%
    • Past 1 month: 10.23%
    • Past 3 months: 33.86%
    • Past 6 months: 40.53%
    • Past 1 year: 62.58%
    • Past 3 years: 151.54%
    • Past 5 years: 262.09%

  3. What are the peers or stocks similar to Genesis IBRC India Ltd (GENESIS)?
  4. What is the market cap of Genesis IBRC India Ltd (GENESIS) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Genesis IBRC India Ltd (GENESIS) is ₹30.41 Cr as of 18th July 2025.

  5. What is the 52 week high and low of Genesis IBRC India Ltd (GENESIS) share?

    The 52-week high of Genesis IBRC India Ltd (GENESIS) is ₹24.55 and the 52-week low is ₹15.10.

  6. What is the PE and PB ratio of Genesis IBRC India Ltd (GENESIS) stock?

    The P/E (price-to-earnings) ratio of Genesis IBRC India Ltd (GENESIS) is 8.66. The P/B (price-to-book) ratio is 6.05.

  7. Which sector does Genesis IBRC India Ltd (GENESIS) belong to?

    Genesis IBRC India Ltd (GENESIS) belongs to the Health Care sector & Biotechnology sub-sector.

  8. How to buy Genesis IBRC India Ltd (GENESIS) shares?

    You can directly buy Genesis IBRC India Ltd (GENESIS) shares on Tickertape. Simply sign up, connect your demat account and place your order.